These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


182 related items for PubMed ID: 27469063

  • 1. Coronary artery bifurcation narrowing treated by Axxess stent implantation: The CARINAX registry.
    Briguori C, Donahue M, Visconti G, Focaccio A, Pennacchi M, Lucisano L, Stio R, Mancone M, Calcagno S, Di Palma V, Labalestra N, Signoriello G, Sardella G.
    Catheter Cardiovasc Interv; 2017 Mar 01; 89(4):E112-E123. PubMed ID: 27469063
    [Abstract] [Full Text] [Related]

  • 2. Comparative Case-Control analysis of a dedicated self-expanding Biolimus A9-eluting Bifurcation stent versus provisional or mandatory side branch intervention strategies in the treatment of coronary bifurcation lesions.
    Ohlow MA, Farah A, Richter S, El-Garhy M, von Korn H, Lauer B.
    Catheter Cardiovasc Interv; 2017 Jul 01; 90(1):39-47. PubMed ID: 27651317
    [Abstract] [Full Text] [Related]

  • 3. Baseline and 9 months IVUS analysis of the bifurcation-dedicated biolimus A9-eluting Axxess stent system: the DIVERGE IVUS substudy.
    Buysschaert I, Sanidas E, Hasegawa T, Koo BK, Honda Y, Fitzgerald PJ, Verheye S.
    Catheter Cardiovasc Interv; 2014 Dec 01; 84(7):1062-70. PubMed ID: 24478226
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. COmplex coronary Bifurcation lesions: RAndomized comparison of a strategy using a dedicated self-expanding biolimus-eluting stent versus a culotte strategy using everolimus-eluting stents: primary results of the COBRA trial.
    Dubois C, Bennett J, Dens J, De Cock D, Desmet W, Belmans A, Ughi GJ, Sinnaeve P, Vrolix M, D'hooge J, Adriaenssens T.
    EuroIntervention; 2016 Apr 20; 11(13):1457-67. PubMed ID: 25947278
    [Abstract] [Full Text] [Related]

  • 9. Analysis of bifurcation lesions treated with novel drug-eluting dedicated bifurcation stent system: intravascular ultrasound results of the AXXESS PLUS trial.
    Miyazawa A, Ako J, Hassan A, Hasegawa T, Abizaid A, Verheye S, McClean D, Neumann FJ, Grube E, Honda Y, Fitzgerald PJ.
    Catheter Cardiovasc Interv; 2007 Dec 01; 70(7):952-7. PubMed ID: 18044777
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
    Triantafyllis AS, Bennett J, Pagourelias E, McCutcheon K, Adriaenssens T, Sinnaeve PR, Desmet W, Dubois C.
    Cardiol J; 2018 Dec 01; 25(4):470-478. PubMed ID: 29240962
    [Abstract] [Full Text] [Related]

  • 11. Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system.
    Verheye S, Buysschaert I, Grube E.
    EuroIntervention; 2015 Dec 01; 11(8):860-7. PubMed ID: 26696454
    [Abstract] [Full Text] [Related]

  • 12. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
    Bennett J, Adriaenssens T, Desmet W, Dubois C.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):843-853. PubMed ID: 27184586
    [Abstract] [Full Text] [Related]

  • 13. Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study.
    Kern A, Gil RJ, Bojko K, Rzeszowski B, Bednarski K, Górny J, Bil J.
    Cardiol J; 2018 Nov 15; 25(2):188-195. PubMed ID: 28714525
    [Abstract] [Full Text] [Related]

  • 14. A randomized trial of a dedicated bifurcation stent versus provisional stenting in the treatment of coronary bifurcation lesions.
    Généreux P, Kumsars I, Lesiak M, Kini A, Fontos G, Slagboom T, Ungi I, Metzger DC, Wykrzykowska JJ, Stella PR, Bartorelli AL, Fearon WF, Lefèvre T, Feldman RL, LaSalle L, Francese DP, Onuma Y, Grundeken MJ, Garcia-Garcia HM, Laak LL, Cutlip DE, Kaplan AV, Serruys PW, Leon MB.
    J Am Coll Cardiol; 2015 Feb 17; 65(6):533-43. PubMed ID: 25677311
    [Abstract] [Full Text] [Related]

  • 15. Prospective multicentre clinical performance evaluation of second and third generation zotarolimus-eluting stents to treat patients with bifurcated coronary lesions.
    Burzotta F, Summaria F, Latib A, De Vita M, Fantoni C, Benedetto S, Turturo M, Larosa C, Manzoli A, Trani C.
    Catheter Cardiovasc Interv; 2016 Jan 01; 87(1):15-22. PubMed ID: 25914397
    [Abstract] [Full Text] [Related]

  • 16. Comparison of sirolimus eluting stent with bioresorbable polymer to everolimus eluting stent with permanent polymer in bifurcation lesions: Results from CENTURY II trial.
    Orvin K, Carrie D, Richardt G, Desmet W, Assali A, Werner G, Ikari Y, Fujii K, Goicolea J, Dangoisse V, Manari A, Saito S, Wijns W, Kornowski R.
    Catheter Cardiovasc Interv; 2016 May 01; 87(6):1092-100. PubMed ID: 26268482
    [Abstract] [Full Text] [Related]

  • 17. Serial intravascular ultrasound analysis of complex bifurcation coronary lesions treated with the Tryton Bifurcation Stent in conjunction with an everolimus-eluting stent: IUVANT (Intravascular Ultrasound Evaluation of Tryton Stent) study.
    Bartorelli AL, Trabattoni D, Almonacid A, Fabbiocchi F, Montorsi P, Galli S, Grancini L, Ravagnani P, Mintz GS, Kaplan AV, Popma JJ, Maehara A.
    Catheter Cardiovasc Interv; 2015 Mar 01; 85(4):544-53. PubMed ID: 25115944
    [Abstract] [Full Text] [Related]

  • 18. Results of the self-expandable BA9 stent for treatment of large angle coronary bifurcation.
    Lucisano L, Calcagno S, Pennacchi M, Stio RE, Mancone M, Sardella G.
    Minerva Cardioangiol; 2014 Feb 01; 62(1):19-27. PubMed ID: 24500214
    [Abstract] [Full Text] [Related]

  • 19. Long-term clinical outcomes after percutaneous coronary intervention for ostial/mid-shaft lesions versus distal bifurcation lesions in unprotected left main coronary artery: the DELTA Registry (drug-eluting stent for left main coronary artery disease): a multicenter registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.
    Naganuma T, Chieffo A, Meliga E, Capodanno D, Park SJ, Onuma Y, Valgimigli M, Jegere S, Makkar RR, Palacios IF, Costopoulos C, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Capranzano P, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A.
    JACC Cardiovasc Interv; 2013 Dec 01; 6(12):1242-9. PubMed ID: 24355114
    [Abstract] [Full Text] [Related]

  • 20. Clinical outcomes following bifurcation double-stenting with bioresorbable scaffolds.
    Tanaka A, Latib A, Kawamoto H, Jabbour RJ, Mangieri A, Pagnesi M, Montalto C, Regazzoli D, Ancona M, Chieffo A, Carlino M, Montorfano M, Colombo A.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(6):854-862. PubMed ID: 27184769
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.